RxDoctor Payments Data

Tanya Guthmiller

Family · Bismarck, NDNPI 1740333616

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 39.9% of the total. 2025 is the largest year on record at $948, 2.2 times the $434 reported in 2021. Among family clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,609in general payments, 2019–2025

Across 178 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Boston Scientific$557
  • Nevro Corp.$536
  • Pfizer$392
  • Medtronic$185
  • Averitas Pharma Inc.$88
  • plus $410 from 10 others

What the payments were for

  • Food & beverage$3,609100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,609 in reported general payments places this provider in the 95th percentile of 496 family providers in North Dakota.

See all family providers in North Dakota

Medicare billing

Part B allowed, 2024
$64,370
Medicare patients
306
Services billed
1,015

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen346$7,189
Gabapentin346$5,803
Pregabalin194$3,613
Duloxetine Hcl198$3,014
Oxycodone Hcl172$2,060
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen96$1,780
Lidocaine16$1,576
Levetiracetam24$1,030
Tizanidine Hcl104$947
Baclofen83$665
Methocarbamol56$621
Cyclobenzaprine Hcl106$581
Diclofenac Sodium35$452
Morphine Sulfate18$442
Hydromorphone Hcl21$411

Paid to pharmacies, not to this prescriber.

Other family in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →